Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy

References

• Minkin C. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982; 34: 285–290
   PubMed Web of Science ®Google Scholar
• Hayman AR, Bune AJ, Bradley JR, Rashbass J, Cox TM. Osteoclastic tartrate resistant acid phosphatase (Acp 5): Its localisation to dendritic cells and diverse murine tissues. J Histochem Cytochem 2000; 48: 219–227
   PubMed Web of Science ®Google Scholar
• Hayman AR, Macary P, Lehner PJ, Cox TM. Tartrate-resistant acid phosphatase (Acp 5): Identification in diverse human tissues and dendritic cells. J Histochem Cytochem 2001; 49: 675–683
   PubMed Web of Science ®Google Scholar
• Li CY, Yam LT, Lam KW. Studies of acid phosphatase isoenzymes in human leukocytes. Demonstration of isoenzyme cell specificity. J Histochem Cytochem 1970; 18: 901–910
   PubMed Web of Science ®Google Scholar
• Burstone MS. Histochemical demonstration of acid phosphatase activity in osteoclasts. J Histochem Cytochem 1959; 7: 39–41
   PubMed Web of Science ®Google Scholar
• Perez-Amodio S, Jansen DC, Schoenmaker T, Vogels IMC, Reinheckel T, Hayman AR, Cox TM, Saftig P, Beertsen W, Everts V. Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity. Calcif Tissue Int 2006; 79: 245–254, Published online October 11, 2006; doi: 10.1007/s00223-005-0289-z
   Google Scholar
• Efstratiadis T, Moss DW. Tartrate-resistant acid phosphatase in human alveolar macrophages. Enzyme 1985; 34: 140–143
   PubMedGoogle Scholar
• Yamamoto T, Nagai H. Ultrastructural localization of tartrate-resistant acid phosphatase activity in rat osteoblasts. J Electron Microsc (Tokyo) 1998; 47: 659–663
   PubMed Web of Science ®Google Scholar
• Perez-Amodio S, Vogels IM, Schoenmaker T, Jansen DC, Alatalo SL, Halleen JM, Beertsen W, Everts V. Endogenous expression and endocytosis of tartrate-resistant acid phosphatase (TRACP) by osteoblast-like cells. Bone 2005; 36: 1065–1077
   Google Scholar
• Hayman AR, Bune AJ, Cox TM. Widespread expression of tartrate-resistant acid phosphatase (Acp 5) in the mouse embryo. J Anat 2000; 196: 433–441
   Google Scholar
• Hayman AR, Dryden AJ, Chambers TJ, Warburton MJ. Tartrate-resistant acid phosphatase from human osteoclastomas is translated as a single polypeptide. Biochem J 1991; 277: 631–634
   Google Scholar
• Lang P, Schultzberg M, Andersson G. Expression and distribution of tartrate-resistant purple acid phosphatase in the rat nervous system. J Histochem Cytochem 2001; 49: 379–396
   Google Scholar
• Lord DK, Cross NCP, Bevilacqua MA, Rider SH, Gorman PA, Groves AV, Moss DW, Sheer D, Cox TM. Type 5 acid phosphatase. Sequence, expression and chromosomal localization of a differentiation-associated protein of the human macrophage. Eur J Biochem 1990; 189: 287–293
   PubMedGoogle Scholar
• Kirstein B, Chambers TJ, Fuller K. Secretion of tartrate-resistant acid phosphatase by osteoclasts correlates with resorptive behaviour. J Cell Biochem 2006; 98: 1085–1094
   PubMed Web of Science ®Google Scholar
• Reinholt FP, Widholm SM, Ek-Rylander B, Andersson G. Ultrastructural localization of a tartrate-resistant acid phosphatase in bone. J Bone Miner Res 1990; 5: 1055–1061
   PubMedGoogle Scholar
• Halleen JM, Raisanen S, Salo JJ, Reddy SV, Roodman GD, Hentunen TA, Lehenkari PP, Kaija H, Vihko P, Vaananen HK. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 1999; 274: 22907–22910
   PubMed Web of Science ®Google Scholar
• Chamberlain P, Compston J, Cox TM, Hayman AR, Imrie RC, Reynolds K, Holmes SD. Generation and characterisation of monoclonal antibodies to human type-5 tartrate-resistant acid phosphatase: Development of a specific immunoassay of the isozyme in serum. Clin Chem 1995; 41: 1495–1499
   PubMed Web of Science ®Google Scholar
• Capeller B, Caffier H, Sutterlin MW, Dietl J. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b serum marker of bone metastases in human breast cancer. Anticancer Res 2003; 23: 1011–1015
   PubMed Web of Science ®Google Scholar
• Yam L, Li CY, Finkel HE. Leukemic reticuloendotheliosis. The role of tartrate-resistant acid phosphatase in diagnosis and splenectomy in treatment. Arch Intern Med 1972; 130: 248–256
   PubMed Web of Science ®Google Scholar
• Luukainen R, Talonen R, Kaarela K, Merilahti-Palo R, Rintala E. Synovial fluid acid phosphatase in seropositive and seronegative arthrides. Clin Exp Rheumatol 1990; 8: 63–65
   Google Scholar
• Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heijjinen JE, Suominen H, Cheng S, Vaananen HK. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif Tissue Int 2002; 71: 20–25
   PubMed Web of Science ®Google Scholar
• Ljusberg J, Ek-Rylander B, Andersson G. Tartrate-resistant purple acid phosphatase is synthesised as a proenzyme and activated by cysteine proteinases. Biochem J 2000; 343: 63–69
   Google Scholar
• Hayman AR, Warburton MJ, Pringle JAS, Coles B, Chambers TJ. Purification and characterisation of a tartrate-resistant acid phosphatase from human osteoclastomas. Biochem J 1989; 261: 601–609
   PubMed Web of Science ®Google Scholar
• Ek-Rylander B, Flores M, Wendal M, Heinegard D, Andersson G. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 1994; 269: 14853–14856
   PubMed Web of Science ®Google Scholar
• Suter A, Everts V, Boyde A, Jones SJ, Lullmann-Rauch R, Hartmann D, Hayman AR, Cox TM, Evans MJ, Meister T, von Figura K, Saftig P. Overlapping functions of lysosomal acid phosphatase (LAP) and tartrate-resistant acid phosphatase (Acp 5) revealed by doubly deficient mice. Development 2001; 128: 4899–4910
   PubMedGoogle Scholar
• Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H. Eta-1 (osteopontin): An early component of type-1 (cell mediated) immunity. Science 2000; 287: 860–864
   PubMed Web of Science ®Google Scholar
• Hayman AR, Cox TM. Tartrate-resistant acid phosphatase: A potential target for therapeutic gold. Cell Biochem Funct 2004; 22: 275–280
   Google Scholar
• Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J. Osteopontin: A molecule for all seasons. Q J Med 2002; 95: 3–13
   Google Scholar
• Bune AJ, Hayman AR, Evans MJ, Cox TM. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen. Staphylococcus aureus. Immunology 2001; 102: 103–113
   Google Scholar
• Hayman AR, Cox TM. Purple acid phosphatase of the human macrophage and osteoclast. Characterisation, molecular properties and crystallization of the recombinant di-iron-oxo protein secreted by baculovirus-infected insect cells. J Biol Chem 1994; 269: 1294–1300
   PubMedGoogle Scholar
• Davis JC, Averill BA. Evidence for a spin-coupled binuclear iron unit at the active site of the purple acid phosphatase from beef spleen. Proc Natl Acad Sci USA 1982; 79: 4623–4627
   Google Scholar
• Raisanen SR, Alatalo SL, Ylipahkala H, Halleen JM, Cassady AI, Hume DA, Vaananen HK. Macrophages overexpressing tartrate-resistant acid phosphatase show altered profile of free radical production and enhanced capacity of bacterial killing. Biochem Biophys Res Commun 2005; 331: 120–126
   PubMed Web of Science ®Google Scholar
• Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, Evans MJ, Cox TM. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 1996; 122: 3151–3162
   PubMed Web of Science ®Google Scholar
• Esfandiari E, Bailey M, Stokes C, Cox TM, Evans MJ, Hayman AR. Tartrate-resistant acid phosphatase (TRACP) influences Th1 pathways by affecting dendritic cell function. J Bone Miner Res 2006; 21: 1367–1376, Published online June 19, 2006; doi: 10.1359/JBMR.060611
   Google Scholar
• Roberts HC, Knott L, Avery NC, Cox TM, Evans MJ, Hayman AR. Altered collagen in tartrate-resistant acid phosphatase (TRAP)-deficient mice: A role for TRAP in bone collagen metabolism. Calcif Tissue Int 2007; 80: 400–410, Published online June 7, 2007; doi:10.1007/s00223-007-9032-2
   Google Scholar
• Hollberg K, Hultenby K, Hayman AR, Cox TM, Andersson G. Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed vesicular transport. Exp Cell Res 2002; 279: 227–238
   PubMed Web of Science ®Google Scholar
• Sheu TJ, Schwarz EM, Martinez DA, O'Keefe RJ, Rosier RN, Zuscik MJ, Puzas JE. A phage display technique identifies a novel regulator of cell differentiation. J Biol Chem 2003; 278: 438–443
   PubMed Web of Science ®Google Scholar
• Johnson RB, Henderson JS. Enhancement by sodium orthovanadate of the formation and mineralization of bone nodules by chick osteoblasts in vitro. Arch Oral Biol 1997; 42: 271–276
   PubMed Web of Science ®Google Scholar
• Raisanen SR, Halleen J, Parikka V, Vaananen HK. Tartrate-resistant acid phosphatase facilitates hydroxyl radical formation and colocalises with phagocytosed Staphylococcus aureus in alveolar macrophages. Biochem Biophys Res Commun 2001; 288: 142–150
   Google Scholar
• Wittrant Y, Theoleyre S, Couillaud S, Dunstan C, Heymann D, Redini F. Regulation of osteoclast protease expression by RANKL. Biochem Biophys Res Commun 2003; 310: 774–778
   Google Scholar
• Wittrant Y, Couillaud S, Theoleyre S, Dunstan C, Heymann D, Redini F. Osteoprotegerin differentially regulates protease expression in osteoclast cultures. Biochem Biophys Res Commun 2002; 293: 38–44
   PubMedGoogle Scholar
• Rivollier A, Mazzorana M, Tebib J, Piperno M, Aitsiselmi T, Rabourdin-Combe C, Jurdic P, Servet-Delprat C. Immature dendritic cell transdifferentiation into osteoclasts: A novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 2004; 104: 4029–4037
   PubMed Web of Science ®Google Scholar
• Speziani C, Rivollier A, Gallois A, Coury F, Mazzorana M, Azocar O, Flacher M, Bella C, Tebib J, Jurdic P, Rabourdin-Combe C, Delprat C. Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines. Eur J Immunol 2007; 37: 747–757
   PubMed Web of Science ®Google Scholar
• Skapenko A, Leipe J, Lipsky PE, Schulze-Koops H. The role of the T cell in autoimmune inflammation. Arthritis Res Ther 2005; 7: S4–S14
   PubMed Web of Science ®Google Scholar
• Petrow PK, Hummel KM, Schedel J, Franz JK, Klein CL, Muller-Ladner U, Kriegsmann J, Changm PL, Prince CW, Gay RE, Day S. Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: Effects of osteopontin on the release of collagenase I in articular chondrocytes and synovial fibroblasts. Arthritis Rheum 2000; 43: 1597–1605
   PubMedGoogle Scholar
• Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT, Noda M. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. PNAS 2002; 99: 4556–4561
   PubMed Web of Science ®Google Scholar
• Honig A, Rieger L, Kapp M, Krockenberger M, Eck M, Dietl J, Kammerer U. Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: An investigational study. BMC Cancer 2006; 6: 199–207
   Google Scholar
• Adams LM, Warburton MJ, Hayman AR. Human breast cancer cell lines and tissues express tartrate-resistant acid phosphatase (TRAP). Cell Biol Int 2007; 31(191)195, Published online October 4, 2006; doi: 10.1016/j.cellbi.2006.09.022
   Google Scholar
• Furger KA, Menon RK, Tuckl AB, Bramwell VH, Chambers AF. The functional and clinical roles of osteopontin in cancer and metastasis. Curr Mol Med 2001; 1: 621–632
   PubMedGoogle Scholar
• Sung V, Gilles C, Murray A, Clarke R, Aaron AD, Azumi N, Thompson EW. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype. Exp Cell Res 1998; 24: 273–284
   Google Scholar
• Nemoto H, Rittling SR, Yoshitake H, Furuya K, Amagasa T, Tsuji K, Nifuji A, Denhardt DT, Noda M. Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues. J Bone Miner Res 2001; 16: 652–659
   Google Scholar